What is the appropriate treatment for a patient with elevated thyroid‑stimulating hormone (TSH) and elevated free thyroxine (FT4)?

Urgent Workup Required: This is NOT Primary Hypothyroidism

This combination of elevated TSH (17.42 μIU/mL) with elevated FT4 (23.65 pmol/L) is biochemically incompatible with primary hypothyroidism and requires immediate investigation for thyroid hormone resistance syndrome, TSH-secreting pituitary adenoma, or assay interference before any treatment is initiated.

Critical Diagnostic Algorithm

Step 1: Rule Out Laboratory Interference (First Priority)

• Immediately repeat TSH and FT4 on a different assay platform 1
• Perform serial dilution study for TSH to exclude heterophile antibodies
• Check for biotin supplementation (discontinue 72 hours before retesting)
• Measure total T4 and T3 to confirm FT4 elevation is real

Step 2: If Results Reproducible, Differentiate the Cause

Check these labs immediately:

• Alpha-subunit (elevated in TSH-secreting adenoma, normal in resistance to thyroid hormone)
• Sex hormone binding globulin (SHBG) (normal/low in RTH, elevated in hyperthyroidism)
• Free T3 level 1
• TRH stimulation test (positive response suggests RTH, blunted/absent suggests TSH-oma)

Step 3: Imaging

• Pituitary MRI with gadolinium to evaluate for TSH-secreting adenoma 1

DO NOT Treat as Primary Hypothyroidism

Critical pitfall: Starting levothyroxine in this scenario could be catastrophic:

• If this is thyroid hormone resistance syndrome, the patient may already be clinically euthyroid or even hyperthyroid despite the elevated TSH 1, 2
• If this is a TSH-secreting adenoma, adding thyroid hormone will worsen hyperthyroidism
• One case report documents a patient with RTH who underwent total thyroidectomy due to misdiagnosis, resulting in years of complicated management 2

Most Likely Diagnoses

1. Resistance to Thyroid Hormone (RTH) Syndrome - Most Common

• Heterozygous mutation in thyroid hormone receptor-β gene (e.g., R320L mutation) 1
• Clinical presentation: Often asymptomatic or mildly hyperthyroid symptoms with goiter
• Labs: Elevated FT4, non-suppressed TSH, normal alpha-subunit, normal/low SHBG
• Partial TSH suppression with high-dose T3 administration 1
• Management: Most patients require NO treatment; they are clinically euthyroid at their elevated hormone levels

2. TSH-Secreting Pituitary Adenoma - Less Common

• Labs: Elevated FT4, elevated TSH, elevated alpha-subunit, elevated SHBG
• Clinical: Hyperthyroid symptoms, possible visual field defects, headaches
• Management: Neurosurgical resection or somatostatin analogs

3. Assay Interference - Must Exclude First

• Heterophile antibodies, biotin, or other interfering substances
• Results don't reproduce on different assay platforms

Immediate Management Steps

1. Do not start levothyroxine
2. Refer urgently to endocrinology (within 1-2 weeks)
3. Assess clinical thyroid status:
   • Heart rate, tremor, heat intolerance, weight changes
   • Goiter examination
   • Neurological exam if pituitary adenoma suspected
4. If patient has hyperthyroid symptoms: Consider beta-blocker for symptomatic relief only
5. If patient has severe symptoms: Hospital admission with endocrine consultation 3

Special Consideration: Recovery Phase of Thyroiditis

The only scenario where elevated TSH with normal-to-high FT4 might be transient is during recovery from thyroiditis 3. However, with TSH of 17.42, this is unlikely unless:

• Recent history of hyperthyroid symptoms followed by hypothyroid symptoms
• Management: Monitor TSH and FT4 in 3-4 weeks; if TSH remains elevated and FT4 drops to low-normal or below, then treat as primary hypothyroidism 3

The key principle: Never treat thyroid dysfunction based on TSH alone when TSH and FT4 are discordant. This pattern demands investigation, not empiric treatment.